Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (14 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.
ShortageSignal

← Scotland alerts

Scotland · NHS Scotland MSAN

Sulfasalazine 250mg/5mL oral suspension (Rosemont)

MSAN(2020)79 · Level 2 · issued 11 Aug 2020

Reference
MSAN(2020)79
Issued
11 Aug 2020
Priority
Level 2
Valid until
End September 2020 - update to MSAN (2020)31 as stated by the source
Source
Signed NHS Scotland notice (PDF) ↗

What the notice states

The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.

ProductPositionResupply
1. Sulfasalazine 250mg/5mL oral suspension is out of stock until end September 2020.Out of stockend September 2020
2. Sulfasalazine 500mg tablets remain available.Available—

Provenance

Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.

scot:msan:2020:79

Recorded
13 Aug 2026 22:03 UTC
Capture route
Captured first-hand by ShortageSignal's scheduled check
Read from
NHS Scotland Medicine Supply Alert Notice (PDF)
Captured at
13 Aug 2026 22:03 UTC
Content hash
9c8b4f528c842febd8623f3d550feec59fd33db4d888f6b3da12a9f34d291626
sha256 of the captured bytes — proves what was captured, not that the source was correct
Source document
https://www.publications.scot.nhs.uk/files/msan-2020-79.pdf ↗

From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.